Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:dateCreated
1994-1-10
pubmed:abstractText
Thapsigargin, an inhibitor of the microsomal Ca2+ pumps, has been extensively used to study the intracellular Ca2+ pool participating in the generation of the agonist-induced Ca2+ signal in various cell types. A dual effect of this agent was observed in bovine adrenal zona glomerulosa cells. At nanomolar concentrations, thapsigargin stimulated a sustained Ca2+ influx, probably resulting from Ca(2+)-store depletion. In contrast, when added at micromolar concentrations, thapsigargin prevented the rise in cytosolic free Ca2+ concentration ([Ca2+]c) induced by K+. This inhibitory effect of thapsigargin on voltage-activated Ca2+ channels was confirmed by measuring Ba2+ currents by the patch-clamp technique. Both low-threshold (T-type) and high-threshold (L-type) Ca2+ channels were affected by micromolar concentrations of thapsigargin. Analysis of the current-voltage relationship for T-type channels revealed that thapsigargin did not modify the sensitivity of these channels to the voltage, but decreased the maximal current flowing through the channels. In conclusion, thapsigargin appears to exert a dual effect on adrenal glomerulosa cells. At lower concentrations, this agent induces a sustained Ca2+ entry, whereas at higher concentrations it decreases [Ca2+]c by blocking voltage-activated Ca2+ channels.
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/8257418-1377126, http://linkedlifedata.com/resource/pubmed/commentcorrection/8257418-1662965, http://linkedlifedata.com/resource/pubmed/commentcorrection/8257418-1718167, http://linkedlifedata.com/resource/pubmed/commentcorrection/8257418-1846739, http://linkedlifedata.com/resource/pubmed/commentcorrection/8257418-1917986, http://linkedlifedata.com/resource/pubmed/commentcorrection/8257418-1965707, http://linkedlifedata.com/resource/pubmed/commentcorrection/8257418-2019269, http://linkedlifedata.com/resource/pubmed/commentcorrection/8257418-2138778, http://linkedlifedata.com/resource/pubmed/commentcorrection/8257418-2420465, http://linkedlifedata.com/resource/pubmed/commentcorrection/8257418-2435728, http://linkedlifedata.com/resource/pubmed/commentcorrection/8257418-2447886, http://linkedlifedata.com/resource/pubmed/commentcorrection/8257418-2451250, http://linkedlifedata.com/resource/pubmed/commentcorrection/8257418-2460443, http://linkedlifedata.com/resource/pubmed/commentcorrection/8257418-2558878, http://linkedlifedata.com/resource/pubmed/commentcorrection/8257418-2663854, http://linkedlifedata.com/resource/pubmed/commentcorrection/8257418-3261266, http://linkedlifedata.com/resource/pubmed/commentcorrection/8257418-3597361, http://linkedlifedata.com/resource/pubmed/commentcorrection/8257418-3713520, http://linkedlifedata.com/resource/pubmed/commentcorrection/8257418-3830061, http://linkedlifedata.com/resource/pubmed/commentcorrection/8257418-6746627, http://linkedlifedata.com/resource/pubmed/commentcorrection/8257418-8382595, http://linkedlifedata.com/resource/pubmed/commentcorrection/8257418-8473301
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Dec
pubmed:issn
0264-6021
pubmed:author
pubmed:issnType
Print
pubmed:day
1
pubmed:volume
296 ( Pt 2)
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
309-12
pubmed:dateRevised
2010-11-18
pubmed:meshHeading
pubmed:year
1993
pubmed:articleTitle
Thapsigargin inhibits voltage-activated calcium channels in adrenal glomerulosa cells.
pubmed:affiliation
Division of Endocrinology, University Hospital, Geneva, Switzerland.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't